← Back to Search

Artificial Disc Replacement

PerQdisc® Nucleus Replacement Device. for Degenerative Disc Disease

N/A
Waitlist Available
Research Sponsored by Spinal Stabilization Technologies
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days
Awards & highlights

Study Summary

This trial will test a new device to treat chronic low back pain. The device is placed minimally invasively and safety data will be collected.

Eligible Conditions
  • Chronic Lower Back Pain
  • Degenerative Disc Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Improvement in back pain as measured by 10-centimeter Visual Analog Scale (VAS)
Improvement in degree of disability as measured by the Oswestry Disability Index (ODI)
MRI assessment of the endplate Modic changes.
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Nucleus ReplacementExperimental Treatment1 Intervention
All patients that meet the inclusion/exclusion criteria will receive the PerQdisc® Nucleus Replacement Device.

Find a Location

Who is running the clinical trial?

Spinal Stabilization TechnologiesLead Sponsor
4 Previous Clinical Trials
203 Total Patients Enrolled
Michael Hess, MDStudy ChairLondon Spine Clinic/ATOS-Klinik
3 Previous Clinical Trials
153 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
Montreal General Hospital
What portion of applicants met pre-screening criteria?
Met criteria
~1 spots leftby Apr 2025